Alembic Pharma clears USFDA inspection at Vadodara facility

Alembic Pharma clears USFDA inspection at Vadodara facility. The company successfully completed an unannounced USFDA onsite inspection at its Bioequivalence Facility. This confirms compliance with regulatory standards and reduces near-term regulatory risk. A positive outcome for export-market credibility.

📊 STOCKS: $APLLTD | 🏢 SECTOR: Pharma | #MEDIUMIMPACT #USFDA